| Megan L Allen, OTR/L | |
|
204 Sunrise Bluff Ln, Smithfield, VA 23430-2318 | |
| (757) 613-1947 | |
| Not Available |
| Full Name | Megan L Allen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 204 Sunrise Bluff Ln, Smithfield, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669940441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 0119003960 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan L Allen, OTR/L 204 Sunrise Bluff Ln, Smithfield, VA 23430-2318 Ph: (757) 613-1947 | Megan L Allen, OTR/L 204 Sunrise Bluff Ln, Smithfield, VA 23430-2318 Ph: (757) 613-1947 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
Vitala™ a novel, non-invasive continence control device, demonstrated safety and efficacy in providing up to 8 hours of temporary continence to people with an end colostomy, according to results of a study published in the journal Diseases of the Colon & Rectum.
› Verified 3 days ago
Mrs. Andrea Bunch Hayden, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Sunrise Bluff Ln, Smithfield, VA 23430 Phone: 757-537-3002 | |
Carissa Naomi Worm, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 432 Kendall Hvn, Smithfield, VA 23430 Phone: 757-345-9166 | |
Intuitive Home Therapy Concepts Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 224 Villa Dr, Smithfield, VA 23430 Phone: 908-463-1031 | |
Margaret Maria Furman-juda, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 820 West Main St, Special Education Department, Smithfield, VA 23430 Phone: 757-365-1616 |